CoChat

Pharmacometabonomics and personalized medicine

Everett, Jeremy R, Loo, Ruey Leng, Pullen, Francis S · 2013 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine

The DOI matches its Crossref record; 112 of the 113 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Pharmacometabonomics is a new branch of science, first described in 2006 and defined as 'the prediction of the effects of a drug on the basis of a mathematical model of pre-dose metabolite profiles'. Pharmacometabonomics has been used to predict drug metabolism, pharmacokinetics (PK), drug safety and drug efficacy in both animals and humans and is complementary to both pharmacogenomics (PGx) and pharmacoproteomics. METHODS: A literature review using the search terms pharmacometabonomics, pharmacometabolomics, pharmaco-metabonomics, pharmaco-metabolomics and the singular form of all those terms was conducted in October 2012 using PubMed and Web of Science. The review was updated until mid April 2013. RESULTS: Since the original description of pharmacometabonomics in 2006, 21 original publications and eight reviews have emerged, covering a broad range of applications from the prediction of PK to the prediction of drug metabolism, efficacy and safety in humans and animals. CONCLUSIONS: Pharmacometabonomics promises to be an important new approach to the delivery of personalized medicine to improve both drug efficacy and safety for patients in the future. Pharmacometabonomics is particularly powerful as it is sensitive to both genetic and environmental factors such as diet, drug intake and most importantly, a person's microbiome. PGx is now over 50 years old and although it has not achieved as much as some hoped, it is starting to have important applications in personalized medicine. We predict that pharmacometabonomics will be equally important in the next few decades and will be both valuable in its own right and complementary to pharmacoproteomics and PGx.

Overview

Integrity signals

Registry

Crossref · 10.1177/0004563213497929

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 112 references

Research works printed but not linked: 6

  1. Everett JR, 1989, Ann Rep B Royal Soc Chem Phys Methods Tech Part I, 86, Chapter 2, 3
  2. Everett JR, 1991, Anal Proc, 28, 181
  3. Everett JR, 1992, Bioanalytical approaches for drugs, including anti-asthmatics and metabolities, 3
  4. Knapp JS, 2010, Metabolomics : metabolites, metabonomics, and analytical technologies
  5. 10.1146/annurev.anchem.1.031207.113026 · DOI · Paper page
  6. Gutiu IA, 2010, Rom J Intern Med, 48, 187

Cited by

See all 75

Metadata

Authors
Everett, J. R., Loo, R. L., & Pullen, F. S.
Affiliations
  • University of Greenwich (GB)
  • Medway School of Pharmacy (GB)
Venue
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
Published
2013-07-25
Volume
50
Issue
6
Pages
523-545
ISSN
  • 0004-5632 (ISSN-L)
  • 1758-1001
OpenAlex
W2141662174
Cited by
75
References
113
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 6 · 2013: 1
FWCI
1.47
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Annals of Clinical Biochemistry International Journal of Laboratory Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Greenwich Academic Literature Archive (University of Greenwich) (acceptedVersion)
  • Murdoch University Research Portal (submittedVersion)
  • Kent Academic Repository (University of Kent) (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
personalized medicine, drug metabolism prediction, pharmacokinetic prediction, drug safety prediction, drug efficacy prediction, pharmacogenomics, pharmacoproteomics, gut microbiota, mathematical modeling
MeSH terms
Animals, Humans, Magnetic Resonance Spectroscopy, Pharmacology, Mass Spectrometry, Metabolomics, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacometabonomics and personalized medicine. https://app.cochat.ai/papers/10.1177/0004563213497929
The paper
Everett, J. R., Loo, R. L., & Pullen, F. S. (2013). Pharmacometabonomics and personalized medicine. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. https://doi.org/10.1177/0004563213497929

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.